A new report published by the Ada Lovelace Institute and the Nuffield Council on Bioethics (NCOB) have stressed the potential risks associated with the widespread implementation of artificial intelligence (AI) powered genomic health prediction (AIGHP) in the NHS. AIGHP, which uses AI techniques to make predictions about individuals' future health and drug responses based on genomic and other data, has raised concerns about privacy and discrimination, not to mention scientific uncertainty concerning its effectiveness.
The report highlights the need for better data protection guidance and a new model of consent for patients sharing their genomic data while urging policymakers to approach the implementation of AIGHP with caution. The researchers warn against a blanket rollout of AIGHP within the NHS and instead advocate for a targeted approach where there is a clearly defined need.
What is this page?
You are reading a summary article on the Privacy Newsfeed, a free resource for DPOs and other professionals with privacy or data protection responsibilities helping them stay informed of industry news all in one place. The information here is a brief snippet relating to a single piece of original content or several articles about a common topic or thread. The main contributor is listed in the top left-hand corner, just beneath the article title.
The Privacy Newsfeed monitors over 300 global publications, of which more than 5,750 summary articles have been posted to the online archive dating back to the beginning of 2020. A weekly roundup is available by email every Friday.
